Repository logo
 

Efficient circular RNA synthesis for potent rolling circle translation.

Published version
Peer-reviewed

Repository DOI


Change log

Abstract

Circular RNA (circRNA) is a candidate for next-generation messenger RNA therapeutics owing to its remarkable stability. Here we describe trans-splicing-based methods for the synthesis of circRNAs over 8,000 nucleotides. The methods are independent of bacterial sequences, outperform the permuted intron-exon method and allow for the incorporation of RNA modifications. The resulting unmodified circRNAs, which incorporate sequences from human 28S ribosomal RNA, display low immunogenicity and are translated more efficiently than permuted intron-exon-derived circRNAs. Additionally, by using viral internal ribosomal entry sites for rolling circle translation, we show that ribosomes can efficiently read through highly structured internal ribosomal entry sites, enhancing the efficiency of rolling circle translation by over 7,000-fold with respect to previous constructs. The efficient and reliable production of circRNA may facilitate its therapeutic use.

Description

Acknowledgements: We thank N. James, K. Ciazynska and J. Zurcher for providing Fluc, Spike and Cas9 sequences, respectively; A. Herrero Del Valle for providing the A549 cells; and M. Hoepfler for suggestions in RT–qPCR. V.R. discloses support for the research described in this study from the UK Medical Research Council (MC_U105184332) and the Wellcome Trust Senior Investigator award (WT096570). Y.D. discloses support for the research described in this study from the China Postdoctoral Science Foundation (PC2021083) and the Leverhulme Trust (ECF-2022-525). P.K.Z. discloses support for the research described in this study from the German National Academy of Sciences Leopoldina (LPDS 2021-14) and the EMBO (ALTF 778-2021).


Funder: Postdoctoral fellowships from the German National Academy of Sciences Leopoldina (LPDS 2021-14)

Journal Title

Nat Biomed Eng

Conference Name

Journal ISSN

2157-846X
2157-846X

Volume Title

9

Publisher

Springer Nature

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Sponsorship
Leverhulme Trust (ECF-2022-525)
China Postdoctoral Science Foundation (PC2021083)
European Molecular Biology Organization (EMBO) (ALTF 778-2021)
RCUK | Medical Research Council (MRC) (MC_U105184332)
Wellcome Trust (Wellcome) (WT096570)